195 related articles for article (PubMed ID: 35269384)
1. Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy.
Bae E; Yu MY; Moon JJ; Kim JE; Lee S; Han SW; Park DJ; Kim YS; Yang SH
Cells; 2022 Feb; 11(5):. PubMed ID: 35269384
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Klf2-Foxp1-TGFβ signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling.
Li H; Wang Y; Liu J; Chen X; Duan Y; Wang X; Shen Y; Kuang Y; Zhuang T; Tomlinson B; Chan P; Yu Z; Cheng Y; Zhang L; Liu Z; Zhang Y; Zhao Z; Zhang Q; Liu J
Theranostics; 2021; 11(4):1609-1625. PubMed ID: 33408770
[No Abstract] [Full Text] [Related]
3. Role of Krüppel-like factor-2 in kidney disease.
Zhong F; Lee K; He JC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():53-56. PubMed ID: 30298668
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 15 is a key suppressor of podocyte fibrosis under rotational force-driven pressure.
Yu MY; Kim JE; Lee S; Choi JW; Kim YC; Han SS; Lee H; Cha RH; Lee JP; Lee JW; Kim DK; Kim YS; Yang SH
Exp Cell Res; 2020 Jan; 386(1):111706. PubMed ID: 31697927
[TBL] [Abstract][Full Text] [Related]
5. The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins.
Marrone G; Russo L; Rosado E; Hide D; García-Cardeña G; García-Pagán JC; Bosch J; Gracia-Sancho J
J Hepatol; 2013 Jan; 58(1):98-103. PubMed ID: 22989565
[TBL] [Abstract][Full Text] [Related]
6. Reduced Krüppel-Like Factor 2 Aggravates Glomerular Endothelial Cell Injury and Kidney Disease in Mice with Unilateral Nephrectomy.
Zhong F; Mallipattu SK; Estrada C; Menon M; Salem F; Jain MK; Chen H; Wang Y; Lee K; He JC
Am J Pathol; 2016 Aug; 186(8):2021-2031. PubMed ID: 27317905
[TBL] [Abstract][Full Text] [Related]
7. Reduced Krüppel-like factor 2 expression may aggravate the endothelial injury of diabetic nephropathy.
Zhong F; Chen H; Wei C; Zhang W; Li Z; Jain MK; Chuang PY; Chen H; Wang Y; Mallipattu SK; He JC
Kidney Int; 2015 Feb; 87(2):382-95. PubMed ID: 25185079
[TBL] [Abstract][Full Text] [Related]
8. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins.
Marrone G; Maeso-Díaz R; García-Cardena G; Abraldes JG; García-Pagán JC; Bosch J; Gracia-Sancho J
Gut; 2015 Sep; 64(9):1434-43. PubMed ID: 25500203
[TBL] [Abstract][Full Text] [Related]
9. Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.
Wu W; Xiao H; Laguna-Fernandez A; Villarreal G; Wang KC; Geary GG; Zhang Y; Wang WC; Huang HD; Zhou J; Li YS; Chien S; Garcia-Cardena G; Shyy JY
Circulation; 2011 Aug; 124(5):633-41. PubMed ID: 21768538
[TBL] [Abstract][Full Text] [Related]
10. SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension.
Li N; Zhang J; Yan X; Zhang C; Liu H; Shan X; Li J; Yang Y; Huang C; Zhang P; Zhang Y; Bu P
Oncotarget; 2017 Jun; 8(24):39592-39604. PubMed ID: 28465484
[TBL] [Abstract][Full Text] [Related]
11. Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.
Xu Y; Xu S; Liu P; Koroleva M; Zhang S; Si S; Jin ZG
J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29191808
[TBL] [Abstract][Full Text] [Related]
12. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
[TBL] [Abstract][Full Text] [Related]
13. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress.
Rossi J; Rouleau L; Tardif JC; Leask RL
Life Sci; 2010 Jul; 87(3-4):92-9. PubMed ID: 20493886
[TBL] [Abstract][Full Text] [Related]
14. Azilsartan ameliorates ox-LDL-induced endothelial dysfunction via promoting the expression of KLF2.
Li W; Wang C; Zhang D; Zeng K; Xiao S; Chen F; Luo J
Aging (Albany NY); 2021 May; 13(9):12996-13005. PubMed ID: 33946046
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of YAP activation attenuates renal injury and fibrosis in angiotensin II hypertensive mice.
Zhang J; Xu Q; Ren F; Liu Y; Cai R; Yao Y; Zhou MS
Can J Physiol Pharmacol; 2021 Oct; 99(10):1000-1006. PubMed ID: 33852804
[TBL] [Abstract][Full Text] [Related]
16. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function.
Lin Z; Kumar A; SenBanerjee S; Staniszewski K; Parmar K; Vaughan DE; Gimbrone MA; Balasubramanian V; García-Cardeña G; Jain MK
Circ Res; 2005 Mar; 96(5):e48-57. PubMed ID: 15718498
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin suppresses the proangiogenic microenvironment of human hepatic stellate cells via the Kruppel-like factor 2 pathway.
Miao Q; Zeng X; Ma G; Li N; Liu Y; Luo T; Lian J; Chen S
Rev Esp Enferm Dig; 2015 Feb; 107(2):63-71. PubMed ID: 25659387
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Foxp1 Suppresses Atherosclerosis via Modulation of Nlrp3 Inflammasome Activation.
Zhuang T; Liu J; Chen X; Zhang L; Pi J; Sun H; Li L; Bauer R; Wang H; Yu Z; Zhang Q; Tomlinson B; Chan P; Zheng X; Morrisey E; Liu Z; Reilly M; Zhang Y
Circ Res; 2019 Aug; 125(6):590-605. PubMed ID: 31318658
[TBL] [Abstract][Full Text] [Related]
19. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization.
van Thienen JV; Fledderus JO; Dekker RJ; Rohlena J; van Ijzendoorn GA; Kootstra NA; Pannekoek H; Horrevoets AJ
Cardiovasc Res; 2006 Nov; 72(2):231-40. PubMed ID: 16945356
[TBL] [Abstract][Full Text] [Related]
20. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF-κB signalling in a mouse model of hypertension.
Ding H; Zhou Y; Huang H
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):246-254. PubMed ID: 30304543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
